Genetic Therapy Composition Manufacture TRIZ Cases
- Gene-Edited CAR-T Cells to Prevent Fratricide in T Cell Malignancies
Gene editing removes the target antigen and can block TCR signaling, helping CAR-T cells kill malignant T cells without self-destruction.
- Lipid-Coated Nanoparticles for Targeted Uptake and Transfection
Microfluidic lipid-coated nanoparticles improve targeted cellular uptake and transfection while reducing liver and spleen accumulation.
- Purified AAV Formulation for Stability and Aggregation Control
Buffer, cryoprotectant, and non-ionic surfactant combinations keep purified AAV particles stable and limit aggregation during storage and freeze-thaw.
- AAV Vector Stuffer Sequences for Residual DNA Purity
Inert stuffer polynucleotides fill AAV packaging capacity to limit residual DNA encapsidation and improve clinical-grade vector purity.
- Fratricide-Resistant CAR-T Cells for T Cell Malignancies
Target-antigen knockout makes CAR-T cells fratricide-resistant, preserving malignant T cell killing while reducing graft versus host risk.
- Acid-Degradable PEG Lipids for Stable mRNA LNP Endosome Escape
Acid-cleavable PEG lipids and self-assembling peptides stabilize mRNA LNPs in serum, then improve endosome escape and cell uptake.
- Peptide-Modified AAV Capsid for Muscle-Specific Gene Transfer
An RGDLXXL/I capsid motif boosts AAV affinity for αVβ6 to improve muscle transduction after systemic delivery without added off-target uptake.
- p53 Phosphorylation Inhibition for Haematopoietic Stem Cell Gene Therapy
Inhibiting p53 phosphorylation helps transduced haematopoietic stem cells survive DNA stress and improve engraftment.
- Modified AAV6 Capsids for HDR Gene Editing in T Cells
Specific AAV6 capsid peptide changes address the gap between T-cell infectivity and efficient HDR-mediated gene editing for immunotherapy.
- Hybrid Herpes-Assisted Vector Expansion for rAAV Production
A hybrid herpes-assisted vector expansion process improves rAAV yield, potency, and purity from small seed quantities.
- Circularized RNA Production Using DNA Templates for Yield and Stability
CRC sequences and DNA templates enable larger, more stable circularized RNA for improved translation and therapeutic expression.
- CRISPR-Edited CAR-T Cells for Fratricide-Resistant T Cell Malignancies
Deleting CD7 and TRAC creates fratricide-resistant, potentially off-the-shelf CAR-T cells without GvHD.
- MiniCircle DNA Vector for Stable Bispecific Antibody Expression
MiniCircle DNA overcomes plasmid backbone silencing to achieve stable, long-term bispecific antibody production.
- AAV Harvesting via Supernatant Extraction
Modified AAV capsids release into culture media for direct supernatant harvesting, avoiding intracellular debris from cell disruption.
- AAV Capsid Singleton Correction for Packaging Yield
Aligning singletons with functional consensus sequences resolves low packaging yield and transduction efficiency in AAV vectors.
- Factor IX Gene Therapy Codon Optimization for Hemophilia B
Codon optimized Factor IX nucleotide sequences boost protein productivity, resolving the trade-off between high expression and treatment cost.
- Chimpanzee Adenovirus Vector Vaccine Design
Chimpanzee-derived adenovirus vectors elicit potent immune responses, overcoming pre-existing human immunity that limits traditional serotype vaccines.
- Purified Modified mRNA Reprogramming Cells Without Genome Integration
Modified single-strand mRNA reprograms somatic cells without genome integration, eliminating cancer risk from viral delivery while maintaining high efficiency.
- Gene-Edited Immune Cells for Solid Tumor Infiltration
Modifying immune effector cells to enhance proliferation and cytotoxicity.
- Viral Vector Gene Expression Balance for Cancer Immunotherapy
Organizing nucleic acid sequences encoding 4-1BBL, scIL-12, and IL-2 in a specific vector structure overcomes cancer cell immune evasion strategies.
- AAV Vector Anti-IgE Gene Therapy for Allergen Protection
Adeno-associated virus vectors deliver anti-IgE genes to overcome short protection durations from frequent monoclonal antibody injections.
- Automated Stem Cell Transduction via Centrifugal Concentration
Centrifugation chamber concentrates stem cells and viral vectors to resolve low transduction efficiency in automated genetic modification.
- Mitochondrial Genome Editing via Enzymatic Delivery
A protein complex with mitochondrial localization sequences targets nucleic acids for precise editing.
- Recombinant Ad35 Vectors for Targeted Hematopoietic Stem Cell Gene Therapy
Engineered Ad35 vectors reduce immunogenicity while enabling targeted gene delivery to hematopoietic stem cells through CD46 binding.
- HCMV Viral Vectors for Multi-Gene Delivery
Segmented adenoviral vectors enable reliable multi-gene insertion, reducing costs and improving physiological outcomes.
- Avian AAV Vectors Overcoming Primate Antibody Barriers
Avian adeno-associated virus vectors bypass human pre-existing antibodies to enable efficient gene transfer in resistant cells.
- Plasmid DNA Fermentation Yield and Purity Optimization
Fed-batch fermentation with temperature shifts boosts plasmid DNA yield while maintaining purity.
- Chimpanzee Adenovirus Formulation Stability
Stabilized formulations maintain viral integrity at elevated temperatures, eliminating the need for ultra-low cold chain infrastructure.
- Diatomaceous Earth Pre-Filter for Viral Vector Purification
Diatomaceous earth pre-filters remove cells to prevent 0.45 μm membrane clogging by host proteins and DNA.